{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T16:10:32Z","timestamp":1777047032372,"version":"3.51.4"},"reference-count":55,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2025,5,24]]},"DOI":"10.1080\/1750743x.2025.2520153","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:56:27Z","timestamp":1750740987000},"page":"551-559","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating mogamulizumab in the treatment of primary cutaneous T-cell lymphoma"],"prefix":"10.1080","volume":"17","author":[{"given":"M.","family":"Oymanns","sequence":"first","affiliation":[{"name":"Academic Teaching Hospital of the University of Aachen","place":["Krefeld, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Elsayad","sequence":"additional","affiliation":[{"name":"Marburg University Hospital","place":["Marburg, Germany"]},{"name":"Philipps-Universit\u00e4t Marburg","place":["Marburg, Germany"]},{"name":"Marburg University Hospital","place":["Marburg, Germany"]},{"name":"University Cancer Center (UCT) Frankfurt - Marburg","place":["Marburg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wilms","sequence":"additional","affiliation":[{"name":"Academic Teaching Hospital of the University of Aachen","place":["Krefeld, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Dimmers","sequence":"additional","affiliation":[{"name":"Academic Teaching Hospital of the University of Aachen","place":["Krefeld, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Daum-Marzian","sequence":"additional","affiliation":[{"name":"Academic Teaching Hospital of the University of Aachen","place":["Krefeld, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Abu-Dawud","sequence":"additional","affiliation":[{"name":"University of Applied Sciences and Medical University","place":["Hamburg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Motiei","sequence":"additional","affiliation":[{"name":"University of Applied Sciences and Medical University","place":["Hamburg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Assaf","sequence":"additional","affiliation":[{"name":"Academic Teaching Hospital of the University of Aachen","place":["Krefeld, Germany"]},{"name":"University of Applied Sciences and Medical University","place":["Hamburg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049043"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-881268"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14706"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00296-9"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113343"},{"key":"e_1_3_4_7_1","unstructured":"Center for Drug Evaluation and Research. Food and drug administration. multidisciplinary review and evaluation for poteligeo (mogamulizumab-kpkc); application no. 761051Orig1s000. 2018. Web22 Apr. 2019 fda."},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0402-5"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30379-6"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102679"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1324"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/antib13020032"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/23495"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.05.005"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0830"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-625251"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.19610.x"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2697"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0983"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.3575"},{"key":"e_1_3_4_21_1","volume-title":"Poteligeo [package insert]","year":"2018","unstructured":"Poteligeo [package insert]. Bedminster, NJ: Kyowa Kirin, Inc; 2018."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210665200"},{"key":"e_1_3_4_23_1","unstructured":"EMA. European medicines agency (EMA) \u2014 mogamulizumab product information. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/poteligeo-epar-product-information_en.pdf"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.0924"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-600924"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19134"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114395"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114405"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20357"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114459"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18549"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.7539"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2438794"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17523"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20708"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013341"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00624-7"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.0877"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001587"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19801"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15432"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18831"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.8250"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.05.017"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.0884"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/608951"},{"key":"e_1_3_4_48_1","unstructured":"NCT05956041. Pembrolizumab and mogamulizumab in advanced-stage relapsed\/refractory cutaneous T-cell lymphomas. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05956041?cond=sezary&intr=Mogamulizumab&rank=2"},{"key":"e_1_3_4_49_1","unstructured":"NCT06235281. Phototherapy and mogamulizumab in early stage MF (PLIGHT): accessed on 27 May 2025. Available from: https:\/\/www.centerwatch.com\/clinical-trials\/listings\/NCT06235281\/phototherapy-and-mogamulizumab-in-early-stage-mf-plight"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31090400"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113521"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115064"},{"key":"e_1_3_4_53_1","unstructured":"EU Clinical Trials Register. Anti-CCR4 monoclonal antibody (mogamulizumab) and total skin electron beam therapy (TSEB) in patients with stage IB-IIB cutaneous T-Cell lymphoma. 2023 [cited 2025 Apr 16]. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04128072"},{"key":"e_1_3_4_54_1","unstructured":"NCT04256018. Mogamulizumab + Low-dose total skin electron beam Tx in mycosis fungoides & S\u00e9zary syndrome. [cited 2025 Apr 16] Available from: https:\/\/clinicaltrials.gov\/study\/NCT04256018"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010141"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19457"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1750743X.2025.2520153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:24:47Z","timestamp":1763137487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1750743X.2025.2520153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,5,24]]}},"alternative-id":["10.1080\/1750743X.2025.2520153"],"URL":"https:\/\/doi.org\/10.1080\/1750743x.2025.2520153","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}